Further investigation on the reasons for contents of paeoniflorin in commercial Radix Paeoniae Alba of prepared Chinese crude drug lower than the standard of Chinese Pharmacopeia
LIU Jing-jing1,2,3, LIU Xiao1,2,3, CAI Hao1,2,3, LI Song-lin4, CAI Bao-chang1,2,3,4
Chinese Journal of Pharmaceutical Analysis ›› 2010, Vol. 30 ›› Issue (10) : 1817-1821.
Further investigation on the reasons for contents of paeoniflorin in commercial Radix Paeoniae Alba of prepared Chinese crude drug lower than the standard of Chinese Pharmacopeia
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |